LIVV IGF-1 LR3 is formulated to the highest standards, ensuring purity and effectiveness
Other Names for Retatrutide: INN, LY3437943 and UK Status Retatrutide, also known by its development code LY3437943, is an investigational triple receptor agonist being studied for obesity and type 2 diabetes
The following are the common side effects: - Nausea - Vomiting - Bloating - Feeling full very quickly - Constipation or sometimes diarrhea - Fatigue or Dizziness Most of these side effects are temporary and improve over time, which usually happens because the body is adjusting to slower stomach emptying, appetite suppression, and hormonal changes
A Comfortable Space to Begin Your Transformation MEET YOUR PROVIDERS Alex DeGol, FNP At 360 Wellness, our providers work directly with every patient to create a personalized plan that fits your lifestyle, health history, and goals